Cita APA (7a ed.)
Uchimoto, T., Matsuda, T., Komura, K., Fukuokaya, W., Adachi, T., Hirasawa, Y., . . . Urabe, F. (2024). C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma. Targeted Oncology, 19(4), 635-645.
Cita Chicago Style (17a ed.)
Uchimoto, Taizo, et al. "C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma." Targeted Oncology 19, no. 4 (2024): 635-645.
Cita MLA (9a ed.)
Uchimoto, Taizo, et al. "C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma." Targeted Oncology, vol. 19, no. 4, 2024, pp. 635-645.
Precaución: Estas citas no son 100% exactas.